AstraZeneca and Daiichi sign $6.9bn cancer drug deal

29th March 2019 Uncategorised 0

The collaboration is aligned with AstraZeneca’s science-led strategy in oncology.

More: AstraZeneca and Daiichi sign .9bn cancer drug deal
Source: News